Bryce Daines ^UDM

Bryce Daines, Co-Founder & CTO at Modulus Therapeutics, is dedicated to helping cancer patients live longer, healthier lives by discovering next-generation cell therapies. Modulus engineers next-generation immune cell therapies, starting with Natural Killer cells designed for treating solid tumors. The Convergent Design™ platform combines genetic engineering, machine learning, and high-throughput in vivo screening to systematically converge on optimized cell designs. Modulus is committed to discovering cell therapies for patient populations not served by existing treatments, using its platform for Partnerss and developing an internal pipeline of therapeutics.